Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
FL.1.1.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.16.30NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
HH.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
HK.29NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.579NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
N.10NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
P.1.11 (Gamma)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.435NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.445NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.124NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.384NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-4751.81US
XAQNSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.2.3.8NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.569NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.524NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XAYNSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
DJ.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XAENSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.467NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.484NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.476NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
A.19NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
A.18NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.404NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
CV.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.177.46NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.2.3.21NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
A.6NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.530NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-20229.7US
BA.1.17.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.2.75.8NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
CH.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.570NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.633NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
DD.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.136NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.348NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.428.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AJ.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-4751.81US
B.1.459NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.160.29NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.415.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.243.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.98NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-4751.81US
B.1.566NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.480NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.38.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
N/ANSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
DJ.1.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BQ.1.1.73NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used